跳至主要内容
临床试验/EUCTR2014-000785-21-BE
EUCTR2014-000785-21-BE进行中(未招募)不适用

Immunogenicity and Lot-to-Lot Consistency Study of a Quadrivalent Influenza Vaccine in Adult and Elderly Subjects

Sanofi Pasteur0 个研究点目标入组 2,224 人开始时间: 2014年6月10日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
2,224

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Individuals aged over 18 years old on the day of inclusion
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 1112
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1112

排除标准

  • Receipt of any vaccine in the 4 weeks preceding trial vaccination or
  • planned receipt of any vaccine in the 3 weeks following trial vaccination
  • Previous vaccination against influenza with the 2014 Southern Hemisphere formulation or the 2014-2015 Northern Hemisphere vaccine with either the trial vaccine or another vaccine in the previous 6 months
  • Subject is pregnant, or lactating, or of childbearing potential

研究者

相似试验